Patent details
EP2245062 Title: METHODS OF TREATING BONE-LOSS DISORDERS USING A GM-CSF ANTAGONIST
Basic Information
- Publication number:
- EP2245062
- PCT Application Number:
- PCT/US/2009/031126
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP097028310
- PCT Publication Number:
- WO/2009/091905
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- METHODS OF TREATING BONE-LOSS DISORDERS USING A GM-CSF ANTAGONIST
- French Title of Invention:
- PROCÉDÉS DE TRAITEMENT DE TROUBLES DE LA PERTE OSSEUSE EN UTILISANT UN ANTAGONISTE GM-CSF
- German Title of Invention:
- VERFAHREN ZUR BEHANDLUNG VON ERKRANKUNGEN MIT KNOCHENABBAU UNTER VERWENDUNG EINES GM-CSF-ANTAGONISTEN
- SPC Number:
Dates
- Filing date:
- 15/01/2009
- Grant date:
- 25/04/2012
- EP Publication Date:
- 25/04/2012
- PCT Publication Date:
- 23/07/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 03/11/2010
- EP B1 Publication Date:
- 25/04/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 15/01/2013
- Expiration date:
- 15/01/2029
- Renunciation date:
- Revocation date:
- 03/03/2019
- Annulment date:
Owner
- From:
- 15/01/2009
- Name:
- Kalobios Pharmaceuticals Inc.
- Address:
- 260 East Grand Avenue, South San Francisco, CA 94080, United States (US)
Inventor
1
- Name:
- YARRANTON Geoffrey T.
- Address:
- United States (US)
2
- Name:
- BEBBINGTON Christopher R.
- Address:
- United States (US)
Priority
- Priority Number:
- 21218 P
- Priority Date:
- 15/01/2008
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07K 16/24;
Publication
European Patent Bulletin
- Issue number:
- 201921
- Publication date:
- 22/05/2019
- Description:
- Revocation of the European patent
| Filing date | Document type | Number of pages |
|---|